0001415889-23-004107.txt : 20230303
0001415889-23-004107.hdr.sgml : 20230303
20230303161829
ACCESSION NUMBER: 0001415889-23-004107
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230301
FILED AS OF DATE: 20230303
DATE AS OF CHANGE: 20230303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Turitz Andrew
CENTRAL INDEX KEY: 0001726221
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37477
FILM NUMBER: 23704254
MAIL ADDRESS:
STREET 1: C/O TELADOC, INC.
STREET 2: 2 MANHATTANVILLE ROAD, SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Teladoc Health, Inc.
CENTRAL INDEX KEY: 0001477449
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
IRS NUMBER: 043705970
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
BUSINESS PHONE: 2036352002
MAIL ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
FORMER COMPANY:
FORMER CONFORMED NAME: Teladoc, Inc.
DATE OF NAME CHANGE: 20091123
4
1
form4-03032023_090316.xml
X0306
4
2023-03-01
0001477449
Teladoc Health, Inc.
TDOC
0001726221
Turitz Andrew
C/O TELADOC HEALTH, INC.
2 MANHATTANVILLE ROAD, SUITE 203
PURCHASE
NY
10577
false
true
false
false
SVP - CORPORATE DEVELOPMENT
Common Stock
2023-03-01
4
M
0
5389
A
20183
D
Common Stock
2023-03-02
4
S
0
1801
25.362
D
18382
D
Common Stock
2023-03-02
4
M
0
1205
A
19587
D
Common Stock
2023-03-02
4
M
0
2048
A
21635
D
Common Stock
2023-03-02
4
M
0
515
A
22150
D
Common Stock
2023-03-02
4
M
0
1147
A
23297
D
Common Stock
2023-03-02
4
M
0
867
A
24164
D
Common Stock
2023-03-02
4
M
0
437
A
24601
D
Restricted Stock Units
2023-03-01
4
M
0
5389
0
D
Common Stock
5389
10781
D
Restricted Stock Units
2023-03-02
4
M
0
1205
0
D
Common Stock
1205
0
D
Performance Stock Units
2023-03-02
4
M
0
2048
0
D
Common Stock
2048
0
D
Performance Stock Units
2023-03-02
4
M
0
515
0
D
Common Stock
515
0
D
Restricted Stock Units
2023-03-02
4
M
0
1147
0
D
Common Stock
1147
1148
D
Performance Stock Units
2023-03-02
4
M
0
867
0
D
Common Stock
867
867
D
Performance Stock Units
2023-03-02
4
A
0
874
0
A
Common Stock
874
874
D
Performance Stock Units
2023-03-02
4
M
0
437
0
D
Common Stock
437
437
D
Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
Performance stock units convert to shares of TDOC common stock on a one-for-one basis
On March 1, 2022, the reporting person was granted 16,170 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
On March 2, 2020, the reporting person was granted 3,615 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
On March 2, 2021, the reporting person earned 6,146 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021.
On March 2, 2022, the reporting person earned 1,030 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2022.
On March 2, 2021, the reporting person was granted 3,442 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
On March 2, 2022, the reporting person earned 2,602 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022.
Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
Performance award amount determined based on metrics in respect of the issuer's financial results over a two-year performance period ending in 2022.
The performance stock units vest in two substantially equal annual installments beginning on March 2, 2023.
On March 2, 2023, the reporting person earned 874 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023.
/s/ Adam C. Vandervoort, Attorney-in-Fact
2023-03-03